George Weston Limited (WN)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 106.27 |
|---|---|
| 52-week range | 83.18 – 111.49 |
| Return, 1 month / 3 months | +4.0% / +1.9% |
| Return, 1 year / 3 years | +22.2% / +128.8% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 21.3% |
| Worst drawdown (1 year) | -9.3% |
| Average daily value traded | 27.96M CAD |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
George Weston Limited is a Canadian holding company whose main business is food retailing and baking. Through its control of Loblaw, it operates supermarkets, pharmacies and other retail stores serving shoppers across Canada. It also runs a bakery business that supplies packaged breads and baked goods to grocery retailers and foodservice customers. The company is based in Toronto and its holdings span food manufacturing and retail distribution, with the Weston family holding a controlling interest.
George Weston Limited trades under the code WN on the Toronto Stock Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
George Weston Limited (WN) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 106.27 on 27 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 87 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.2% and over the last three months it rose 1.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.0% | ||
| From 52-week high | -3.9% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.9% | ||
| 6-month return | 11.0% | ||
| 12-month return, skipping the last month | 17.5% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -9.3% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 27.96M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | +4.0% |
| 3 months | +1.9% |
| 6 months | +11.0% |
| 1 year | +22.2% |
| 3 years | +128.8% |
| 5 years | +160.3% |
Signals
| 50-day / 200-day average | 101.44 / 99.35 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | CAD 0.3220 |
| 15 Jun 2026 | CAD 0.3220 |
| 13 Mar 2026 | CAD 0.2980 |
| 15 Dec 2025 | CAD 0.2980 |
| 15 Sep 2025 | CAD 0.2980 |
| 13 Jun 2025 | CAD 0.8940 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.